InvestorsHub Logo
Followers 9
Posts 2033
Boards Moderated 0
Alias Born 08/26/2010

Re: PPHMfan post# 60876

Monday, 01/31/2011 4:58:58 PM

Monday, January 31, 2011 4:58:58 PM

Post# of 345996
PPHMfan, thanks so much for sharing your email response. It is refreshing to have someone actually post info good or bad rather than keeping it to themselves!

I sent Amy a message this morning and just got a response. I don't know if this was discussed before or not.

My message...

It’s really good to see some of these trials starting and should make for an exciting 2011. I just have a quick question. Has Marvin R. Garovoy left the company? I no longer see him on the management team part of the website. Any help would be greatly appreciated.

Amy's response...

Yes, we continue to advance our clinical programs for bavituximab and Cotara. Dr. Garovoy was brought on board to establish our new investigator-sponsored trials (IST) program. Following the launch of this program last year and the initiation of the first two of several planned ISTs, Dr. Garovoy is pursuing other professional opportunities outside of Peregrine, and remains available to help us with projects. We appreciate his contributions in establishing this program and mentoring our internal team to execute these ISTs.
Regards,
Amy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News